Inclusion body myositis: Atypical clinical presentations

European Neurology

Volumn 36, Issue 2, 1996, Pages 89-93

  Schlesinger, I ^a   Soffer, D ^a   Lossos, A ^a   Meiner, Z ^a   Argov, Z ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Inclusion body myositis; Post polio syndrome; Scapuloperoneal syndrome; Scleroderma

Indexed keywords

METHYLPREDNISOLONE; STEROID;

ADULT; ARTICLE; AUTOIMMUNITY; CASE REPORT; CELL INCLUSION; CELL VACUOLE; FEMALE; HEREDITARY SPINAL MUSCULAR ATROPHY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; MYOSITIS; POSTPOLIOMYELITIS SYNDROME; PRIORITY JOURNAL; SCLERODERMA; STEROID THERAPY;

ADULT; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INCLUSION BODIES; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; MUSCLE, SKELETAL; MYOSITIS, INCLUSION BODY; NEUROLOGIC EXAMINATION; VACUOLES;

EID: 0030025218     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000117215     Document Type: Article

References (35)

1. Yunis EJ, Samaha FJ: Inclusion body myositis. Lab Invest 1971;25:240-247.
2. Mikol J, Engel AG: Inclusion body myositis: in Engel AG. Banker BQ (eds): Myology: Basic and Clinical. New York. McGraw-Hill 1994, pp 1384-1398.
3. Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ: Inclusion body myositis observations in 40 patients. Brain 1989;1 12:727-747.
4. Sckul EA, Dalakas MC: Inclusion body myositis: New concepts. Semin Neurol 1993; 13:256-263.
5. Askanas V, Engel WK: New advances in inclusion body myositis. Curr Opin Rheumatol 1993:5:732-741.
6. Cole AJ, Kuznieckv RR, Karpali G, Carpenter S, Andermann E, Andermann F: Familial myopathy with changes resembling inclusion body myositis and periventricular leucocnccphalop-athy. Brain 1988;111:1025-1037.
7. Neville HE, Baumbach LL, Ringel SP, Russo LS Jr, Sujansky E, Garcia CA: Familial inclusion body myositis: Evidence for autosomal dominant inheriance. Neurology 1992:42:897-902.
8. Argov Z, Yarom R: ‘Rimmed vacuole myopathy' sparing the quadriceps a unique disorder in Iranian jews. J Neurol Sei 1984:64:33-43.
9. Massa R, Weller B, Karpati G, Shoubridge E. Carpenter S: Familial inclusion body myositis among Kurdish-Iranian Jews. Arch Neurol 1991;48:519-522.
10. Criggs R, Mendell J: Summary of Workshop on Sporadic and Familial Inclusion Body Myopathy. Ann Neurol, in press.
11. Askanas V, Engel WK, Bilak M, Alvarez RB, Selkoe DJ: Twisted tubofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hy-perphosphorylated tau. Am J Palhol 1994:144: 177-187.
12. Mendell JR, Sahenk Z, Gales T, Paul L: Amyloid filaments in inclusion body myositis. Arch Neurol 1991;48:1229-1234.
13. Askanas V, Alvarez RB, Engel WK: β-Amvloid precursor cpitops in muscle fibers of inclusion body myositis. Ann Neurol 1993:34:551-560.
14. Soueidan SA, Dalakas MC: Treatment of inclu-sion-body myosiliswith high-dosc intravenous immunoglobulin. Neurology 1993:43:876-879.
15. Salvarani C, Boiardi L, Manacini R, Maldini MC, Mancini R, Rinaldi M, Macchioni P, Por-tioli J: High dose immunoglobulin therapy in a case of inclusion body myositis: Clinical and immunologic aspects. J Rheumatol 1993;20: 1455-1456.
16. Dalakas MC, Dantbrosia JM, Sekul EA, Cupler EJ, Sivakuntar K: The efficacy of high dose intravenous immunoglobulin (IVlg) in patients with inclusion-body myosilis (IBM). Neurology I995(suppl 4):A208.
17. Danon MJ, Reyes MG, Perurena OH, Masdeu JC, Manaligod JR: Inclusion body myositis a corticosteroid-resistant idiopathic inflammatory myopathy. Arch Neurol 1982:39:760-764.
18. Calabrese LH, Mitsumoto H, Chou SM: Inclusion body myositis presenting as treatment-resistant polvmvositis. Arthritis Rheum 1987: 30:397-403.
19. Richter Cohen M, Suiaiman AR, Garancis JC, Wortman RE: Clinical heterogeneity and treatment response in inclusion body myositis. Arthritis Rheum 1989:32:734-740.
20. Leff RL, Miller FW, Hicks J, Fraser DD, Plotz PH: The treatmcnl of inclusion body myositis: A retrospective and a randomized, prospective trial of immunosuppressive therapy. Medicine 1993:72:225-235.
21. Munsal TL: Fascioscapulohuntcral dystrophy and the scapuloperoneal syndrome; in Engel AG. Banker BQ (eds): Myology: Basic and Clinical. New York. McGraw-Hill. 1986. pp 1251-1266.
22. Dalakas MC, Elder G, Hallet M, Ravits J, Bal-cce M, Papadopoutos N, Albrech P, Sever J: A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms. N Engl J Med 1986:314:959-963.
23. Dalakas MR: Morphologic changes of the muscles of palients with postpoliomyelitis neuromuscular symptoms. Neurology 1988:38:99-104.
24. Figarella-Branger D, Pellisier JF, Bianco N, Devictor B, Toga M: Inflammatory and noninflammatory inclusion body myosilis. Acta Palhol 1990:79:528-536.
25. Abarbanci JM, Lichtenfeld Y, Zirkin H, Lou-zon Z, Osimani A, Farkash P, Herishanu Y: Inclusion body myositis in post-poliomyelitis muscular alrophv. Acta Neurol Scand 1988:78: 81-84.
26. Chou SM: Myxovirus-like structure in a ease of human polymyositis. Science 1967; 158:1453-1455.
27. Mikol J, Fellcn-Papaiconomou A, Ferchl F, Perol Y, Gauthier B, Haguenau M, Pepin B: Inclusion body myositis: clinicopalhological studies and isolation of adenovirus type 2 from muscle biopsy specimen. Ann Neurol 1982; 11 : 576-581.
28. Dalakas MC: Polymyositis, dcrmatomyositis. and inclusion body myosilis. N Engl J Med 1991;325:1487-1498.
29. Chad D, Good P, Adelman L, Bradley WG, Mills J: Inclusion body myositis associated with Sjogren's syndrome. Arch Neurol 1982; 39:186-188.
30. Riggs JE, Schochct SS, Gulmann L, McContas CF. Rogers JS: Inclusion body myositis and chronic immune thrombocytopenia. Arch Neurol 1984:41:93-95.
31. Clements PJ, Furst DE, Campion DS, Bohan A, Harris, Levy J, Paulus HE: Muscle disease in progressive systemic sclerosis. Arthritis Rheum 1978;21:62-71.
32. Averbuch-Heller L, Steiner I, Abramsky O: Neurologic manifestations of progressive systemic sclerosis. Arch Neurol 1992:49:1292-1295.
33. Salama J, Tome FM, Lebon P, Marie L. Dcla-porte P, Fardeau M: Inclusion body myositis: Clinical, morphological, and virological study of a new ease associated with scleroderma and Klinefelter’s syndrome. Rev Neurol 1980:136: 863-878.
34. Helm TM, Valenzuela R, Bergfeld WF, Guilarl J, Poolos CJ: In vivo complement C3 binding lo the intracellular substance and cytoplasm of epidermal basal cells in a patient with scleroderma and inclusion body myositis. J Am Acad Dermatol 1990;23:753-754.
35. Sadch M, Gadoth M, Iladar M, Ben David E: Vacuolar myopathy sparing lite quadriceps. Brain 1993:16:217-232.